Myriad RBM to work with Sanofi to perform biomarker analysis of blood samples from ELIXA trial Oct. 27, 2016
Depletion-free 3D LC/MS quantitative proteomics pilot study identifies prostate cancer biomarkers Oct. 4, 2016